Literature DB >> 6876275

Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients.

J A Smith, J P Seaman, J B Gleidman, R G Middleton.   

Abstract

During the last decade 452 patients have undergone pelvic lymphadenectomy as a staging procedure for apparently localized prostatic cancer. Of these patients 105 (23 per cent) had pelvic node metastasis. Node involvement occurred in no patient with a stage A1, 24 per cent with stage A2, 12 per cent with stage B1, 28 per cent with stage B2 and 53 per cent with stage C tumor. Correlation with tumor grade revealed nodal metastasis in 10 per cent of the patients with well differentiated tumors, 24 per cent with moderately differentiated lesions and 54 per cent with poorly differentiated tumors. The incidence of positive nodes is low enough to preclude lymphadenectomy in patients with stage A1 (0 per cent) and well differentiated stage B1 tumors (4 per cent), and high enough to assume metastatic disease without lymphadenectomy in those with poorly differentiated stage C tumors (93 per cent). All other patients with apparently localized prostatic cancer should undergo a staging pelvic node dissection before definitive treatment.

Entities:  

Mesh:

Year:  1983        PMID: 6876275     DOI: 10.1016/s0022-5347(17)51112-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?

Authors:  Sunny Y Wong; Richard O Hynes
Journal:  Cell Cycle       Date:  2006-04-17       Impact factor: 4.534

2.  The metastatic potential of prostate carcinomas composed entirely of single malignant glands.

Authors:  P N Brawn; C F Johnson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Temporal changes in the clinical approach to diagnosing prostate cancer.

Authors:  William M Hilton; Susan S Padalecki; Donna P Ankerst; Robin J Leach; Ian M Thompson
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

Review 4.  Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy.

Authors:  M C Beduschi; R Beduschi; J E Oesterling
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  The changing pattern of prostate cancer in Nigerians: current status in the southeastern states.

Authors:  Paul D Ekwere; S N Egbe
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

Review 6.  Potential therapeutic strategies for lymphatic metastasis.

Authors:  Bernadette M M Zwaans; Diane R Bielenberg
Journal:  Microvasc Res       Date:  2007-09-19       Impact factor: 3.514

7.  Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.

Authors:  Johanna Tuomela; Maija Valta; Jani Seppänen; Kati Tarkkonen; H Kalervo Väänänen; Pirkko Härkönen
Journal:  BMC Cancer       Date:  2009-10-12       Impact factor: 4.430

8.  Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.

Authors:  Jacqueline Banyard; Ivy Chung; Matthew Migliozzi; Derek T Phan; Arianne M Wilson; Bruce R Zetter; Diane R Bielenberg
Journal:  BMC Cancer       Date:  2014-05-30       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.